DOC PREVIEW
UNC-Chapel Hill ENVR 442 - Biochemical and Molecular Toxicology

This preview shows page 1-2-17-18-19-36-37 out of 37 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 37 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

K.L.R. Brouwer1September 7, 2010TOXC 442Xenobiotic TransportersBiochemical and Molecular ToxicologyENVR 442/TOXC 442/BIOC 442The Role of Transporters (Phase III)in Xenobiotic DispositionKim L.R. Brouwer, PharmD, PhDWilliam R. Kenan Distinguished Professor and Chair,Division of Pharmacotherapy & Experimental TherapeuticsUNC Eshelman School of [email protected]; 919-962-7030Organic Anion TransportersSolute Carrier Family 22Transporter Tissue distribution Transport mechanismSubstratesOAT1 kidney, brain, choroid plexusantiport (dicarboxylates)PAH, PSP, methotrexate (MTX), cidofovir, ochratoxin A (OTA), cephaloridine, indoxyl sulfate, AZT, penicillins, cAMP, cGMP, PGE2, etc.OAT2 kidney, liver ?PAH, MTX, salicylate, acetylsalicylate, PGE2OAT3 kidney, liver, bone, brain, eyeantiport (dicarboxylates)PAH, OTA, salicylate, estrone-sulfate, cAMP, PGE2, cimetidineOAT4 kidney, placenta antiport (dicarboxylates)PAH, OTA, DHEA-sulfate, estrone-sulfate, AZT, cimetidine, MTXF. RusselK.L.R. Brouwer2September 7, 2010TOXC 442Xenobiotic TransportersOrganic Anion Transporting PolypeptidesSolute Carrier Family 21/SLCOTransporter Tissue distribution Transport mechanismSubstratesOatp1 (1a1) kidney, liver antiport(GSH)BSP,ouabain, taurocholate, estradiol glucuronide (E217βG), estrone sulfate, DHEA sulfate, aldosterone, cortisol, enalapril, thyroxine, triiodo-L-thyronine (T3), leukotriene C4, PGE2, ochratoxin AOatp3 (1a5) kidney, lung, retina, liver?taurocholate, thyroxine, T3Oatp5 (1a6) kidney ??Oat-k1/k2 (1a3_v1/v2)OATP-A (1A2)OATP-H (4C1)kidneybrain, kidney, liverkidney?antiport?(GSH)?MTX, folate, DHEA sulfate, E217βG ochratoxin A, digoxin, MTX, AZTBSP, DHEA, estradiol glucuronide, estrone sulfate, thyroxine, T3, ochratoxin A, bile acids, fexofenadine, oubain, rocuronium, chlorambucildigoxin, ouabain, thyroxine, T3, cAMP, MTXF. RusselOrganic Cation TransportersSolute Carrier Family 22Transporter Tissue distribution Transport mechanismSubstratesOCT1 liver uniportMPP+, TEA, acyclovir, ganciclovirOCT2 kidney, brain, neurons uniportTEA, MPP+, NMN, monoamines, amantadineOCT3 liver, skeletal muscle, placenta, kidney, heart, brainuniportMPP+, guanidine, monoamines, cimetidine, tyramineOCTN1 kidney, skeletal muscle, placenta, prostate, heartantiport (H+)TEA, MPP+, carnitine, quinidine, verapamil, pyrilamineOCTN2 skeletal muscle, kidney, placenta, liver, intestine, heart, etc.uniport Na+-carnitine cotransportTEA, MPP+, carnitine, choline, quinidine, verapamil, pyrilamine, valproateF. RusselK.L.R. Brouwer3September 7, 2010TOXC 442Xenobiotic TransportersTransporter Tissue distribution Transport mechanismSubstratesMRP1 kidney, (liver), lung, intestine, brainpump (ATP)glutathione, glucuronide, and sulfate conjugates, anticancer agents, GSH, GSSG, PAHMRP2 kidney, liver, intestine pump (ATP) glutathione, glucuronide, and sulfate conjugates, PAH, GSH, GSSG, cisplatin, methotrexate, ochratoxin AMRP4 kidney, liver, intestine, brain, prostatepump (ATP)cidofovir, PMEA, AZTMP, MTX, PAH, cAMP, cGMP, prostaglandinsMRP6MDR1kidney, liverkidney, liver, intestine, brain, placenta, lungpump (ATP)pump (ATP)BQ123, glutathione conjugatesE217βG, calcein, rhodamine 123, digoxin, anticancer drugs, verapamil, anti-HIV drugs, steroid hormonesMultidrug Resistance TransportersATP-Binding Cassette subfamily (ABCB/ABCC)outinNH2COOHATPATPoutinNH2COOHATPATPoutinoutinNH2COOHATPATPoutinoutinNH2COOHATPATPMRP1MRP2MRP6MRP4MRP5MDR1F. RusselAyrton & Morgan, Xenobiotica 31:469, 2001Organ Distribution of Transport Proteins BSEPK.L.R. Brouwer4September 7, 2010TOXC 442Xenobiotic TransportersMdr1a P-gpMdr1b P-gpBBBGallbladderLiverStomachIntestineKidneyAdapted fromSchinkel, 1997Organ Distribution of Multidrug Resistance Mdr1 P-glycoproteinP-gp Expression in Murine Brain Capillary Endothelial CellsGraff and Pollack, 2005K.L.R. Brouwer5September 7, 2010TOXC 442Xenobiotic TransportersIvermectin Toxicity inMdr1a(-/-) and Mdr1a(+/+) MiceSchinkel et al., Cell, 77:491, 1994Maintenance of Barrier Function:Xenobiotic Transporters in the BrainHo and Kim, Clin Pharmacol Ther 78:260, 2005K.L.R. Brouwer6September 7, 2010TOXC 442Xenobiotic TransportersP-glycoprotein stainingEndothelial cell stainingCo-localizationMaintenance of Barrier Function:Endothelial Cells Lining the Olfactory BulbGraff and Pollack, Pharm Res 22:86, 2005Maintenance of Barrier Function in Sanctuary Site TissuesPlacentaLeslie et al., Tox Appl Pharmacol 204:216, 2005K.L.R. Brouwer7September 7, 2010TOXC 442Xenobiotic TransportersMaintenance of Barrier Function:Xenobiotic Transporters in the IntestineHo and Kim, Clin Pharmacol Ther 78:260, 2005Role of Mrp1 in Intestinal Toxicity of MethotrexateIntestinal toxicity induced by methotrexate treatment in wild-type [Mrp1(+/+)] and Mrp1 gene knockout [Mrp1(−/−)] mice in vivo. Mrp1 is localized primarily in proliferative cells in crypts where it is involved in active efflux of methotrexate as a defensive mechanism to protect the small intestinal epithelial cells from toxicity.Tissue sections from ‘lower’ part of the small intestine were analyzed for morphology with H&E staining (top panel) and for S-phase cells with immunostaining using anti-BrdU antibody (bottom panel).Ho and Kim, Clin Pharmacol Ther 78:260, 2005K.L.R. Brouwer8September 7, 2010TOXC 442Xenobiotic TransportersXenobiotic Transporters in the KidneyHo and Kim, Clin Pharmacol Ther 78:260, 2005Effect of Probenecid on Renal Content and Urinary Excretion of Cadmium (Cd) in Mice Mice were injected i.p. with saline or probenecid (1 mmol/kg), and injected i.v. 30 min later with either Cd alone (1 mg Cd/kg, 74 kBq 109Cd) or Cd with dithiocarbamate chelating agents (1:30 molar ratio); urine samples were collected for 3 h and renal Cd content was determined from radioactivity.Kamenosono et al., Comp Biochem Physiol C Toxicol Pharmacol 132:61, 2002K.L.R. Brouwer9September 7, 2010TOXC 442Xenobiotic TransportersNPT1pOatv1OAT1/3MRP6α-KGOat1/3Mrp6α-KGOAT4MRP2/4α-KGOat4Mrp2/4α-KGOCT2Oct1/2MDR1OCTN1/2H+Mdr1a/1bOctn1/2H+OATP4C1Oatp4c1OATP1A2GSHGSHOatp1a1Oatp1a3(Oat-k1/k2)Oatp1a4/a5blood bloodurinehumanratSpecies differencesF. RusselAvailable Models To ExamineRenal Transport Processes Intact kidney in vivo Isolated perfused kidney Isolated perfused or nonperfused tubules  Cultured renal cells Isolated plasma membrane vesicles(basolateral or brush border)K.L.R. Brouwer10September 7, 2010TOXC 442Xenobiotic TransportersHepatic Elimination: Phase I (P450s),Phase II (conjugation) &


View Full Document

UNC-Chapel Hill ENVR 442 - Biochemical and Molecular Toxicology

Documents in this Course
Load more
Download Biochemical and Molecular Toxicology
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view Biochemical and Molecular Toxicology and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view Biochemical and Molecular Toxicology 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?